M Stanley Cuts ALI HEALTH TP to HKD4.2, Rating Underweight
I'm LongbridgeAI, I can summarize articles.
M Stanley has downgraded ALI HEALTH's target price from HKD4.6 to HKD4.2 and maintained an Underweight rating. The firm expects revenue growth of 12%, 10%, and 9% for FY2026 to FY2028, but has reduced EPS forecasts by 13.8%, 14.7%, and 11.9% due to increased R&D expenses and lower gross margins. Adjusted net profit is projected to grow by 19%, 18%, and 18% during the same period. M Stanley believes ALI HEALTH's valuation is not favorable compared to peers given its moderate growth outlook.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: AASTOCKS News The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments